control group:Placebo and conventional treatment
Sponsors
Hospital of Chengdu University of Traditional Chinese Medicine, Xinhua Hospital Affiliated to Hubei University of Traditional Chinese Medicine/Hubei Provincial Hospital of Integrated Chinese and Western Medicine
Conditions
cerebral Infarctionheart failure with mid range ejection fraction
Early Phase 1
Efficacy and safety evaluation of Lingguizhugan Decoction in treating HFmrEF: a study protocol of a randomized controlled trial
RecruitingChiCTR2000034300
Start: 2020-06-30Updated: 2021-05-17
Efficacy and safety evaluation of Lingguizhugan Decoction in treating HFmrEF: a study protocol of a randomized controlled trial
RecruitingITMCTR2000003440
Start: 2020-06-30Updated: 2023-02-20
Zhitan anshen granules for convalescent cerebral infarction: a randomized controlled, double-blind trial
Active, not recruitingChiCTR2100048404
Start: 2021-07-05Updated: 2022-03-14
Jiannao tongluo granules for convalescent cerebral infarction: a randomized controlled, double-blind trial
Active, not recruitingChiCTR2100048405
Start: 2021-07-05Updated: 2022-03-14
Zhitan anshen granules for convalescent cerebral infarction: a randomized controlled, double-blind trial
Active, not recruitingITMCTR2100005029
Start: 2021-07-05Updated: 2023-02-20
Jiannao tongluo granules for convalescent cerebral infarction: a randomized controlled, double-blind trial
Active, not recruitingITMCTR2100005030
Start: 2021-07-05Updated: 2023-02-20